<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://neogen.it/sitemaps.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">	<url>
				<loc>https://neogen.it/</loc>
				<lastmod>2026-09-10T12:18:06+00:00</lastmod>
				</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/malattie-rare-il-nostro-percorso-verso-un-unico-brand/</loc>
				<lastmod>2026-09-16T07:18:26+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/rare-diseases-our-journey-toward-a-single-brand/</loc>
				<lastmod>2026-09-16T07:17:39+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/berotralstat-commissione-europea-autorizza-uso-pediatrico-prima-profilassi-orale-disponibile/</loc>
				<lastmod>2026-09-07T08:47:37+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/berotralstat-european-commission-approves-pediatric-use-first-oral-prophylactic-treatment-now-available/</loc>
				<lastmod>2026-09-07T08:47:13+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/chmp-issues-a-positive-opinion-on-the-paediatric-extension-of-berotralstat-for-the-treatment-of-hereditary-angioedema/</loc>
				<lastmod>2026-07-06T13:35:46+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/il-chmp-esprime-parere-positivo-per-lestensione-pediatrica-di-berotralstat-nel-trattamento-dellangioedema-ereditario/</loc>
				<lastmod>2026-07-06T13:35:24+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-s-p-a-successfully-completes-the-placement-of-its-e890-million-senior-secured-floating-rate-notes-due-2033/</loc>
				<lastmod>2026-07-02T10:51:08+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-ha-concluso-con-successo-il-collocamento-di-senior-secured-floating-rate-notes-con-scadenza-2033-per-un-ammontare-pari-a-e890-milioni/</loc>
				<lastmod>2026-07-02T10:49:02+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/haello-were-heare-the-event-to-raise-awareness-of-hereditary-angioedema/</loc>
				<lastmod>2026-06-05T09:46:06+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/haello-were-heare-its-not-what-it-seems-decode-the-rare/</loc>
				<lastmod>2026-06-05T09:44:59+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-exclusive-rights-to-navenibart-in-europe-from-biocryst-pharmaceuticals/</loc>
				<lastmod>2026-05-05T10:16:29+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-diritti-esclusivi-per-navenibart-in-europa-da-biocryst-pharmaceuticals/</loc>
				<lastmod>2026-05-05T10:15:20+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentilis-scientific-event-in-milan-experts-shine-a-spotlight-on-leg-health/</loc>
				<lastmod>2026-03-26T13:24:47+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/a-milano-levento-scientifico-di-neopharmed-gentili-gli-esperti-accendono-i-riflettori-sulla-salute-delle-gambe/</loc>
				<lastmod>2026-03-26T13:20:54+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-colloca-bond-da-e750-milioni/</loc>
				<lastmod>2026-02-04T11:08:43+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/new-licensing-agreement-with-lupin-limited-for-the-commercialization-and-promotion-of-plasil-in-brazil-and-the-philippines/</loc>
				<lastmod>2025-12-18T10:34:00+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/nuovo-accordo-di-licenza-con-lupin-limited-per-la-commercializzazione-e-la-promozione-di-plasil-in-brasile-e-nelle-filippine/</loc>
				<lastmod>2025-12-18T10:32:35+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-completes-acquisition-of-european-orladeyo-business-from-biocryst-pharmaceuticals/</loc>
				<lastmod>2025-12-10T13:50:33+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-supports-sport-as-a-tool-for-inclusion-and-freedom/</loc>
				<lastmod>2025-12-10T13:49:59+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/ipnosis-levento-di-neopharmed-gentili-sullinsonnia/</loc>
				<lastmod>2025-12-05T11:32:31+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/hypnosis-a-neopharmed-gentili-s-event-on-insomnia/</loc>
				<lastmod>2025-12-05T11:32:04+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/nb-renaissance-new-partner-for-neopharmed-gentili-and-ardian/</loc>
				<lastmod>2025-12-01T10:15:23+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/eric-falcand-is-the-new-ceo-of-neopharmed-gentili/</loc>
				<lastmod>2025-11-26T11:16:55+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-metoclopramide-product/</loc>
				<lastmod>2025-11-26T08:39:58+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/sports-and-disability-a-winning-combination/</loc>
				<lastmod>2025-11-26T08:37:44+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/erectile-dysfunction-raising-awareness/</loc>
				<lastmod>2025-11-24T16:20:29+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/annual-report-social-2020-neopharmed-gentili/</loc>
				<lastmod>2025-11-24T15:08:29+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-al-fianco-di-fondazione-libellula/</loc>
				<lastmod>2025-11-24T09:24:05+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-alongside-fondazione-libellula/</loc>
				<lastmod>2025-11-24T09:22:24+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-il-business-europeo-orladeyo-da-biocryst-pharmaceuticals/</loc>
				<lastmod>2025-11-21T16:26:04+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-donates-medicines-for-ukraine/</loc>
				<lastmod>2025-11-21T15:03:05+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-donates-50000-euros-for-the-earthquake-in-turkey/</loc>
				<lastmod>2025-11-20T15:08:01+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-s-p-a-places-an-amount-of-e100-million-of-senior-secured-notes/</loc>
				<lastmod>2025-11-19T09:47:23+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/italian-pharma-firms-driving-force-of-the-national-economy/</loc>
				<lastmod>2025-11-19T09:17:07+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/a-responsible-and-solid-commitment-to-our-people-the-environment-and-the-community/</loc>
				<lastmod>2025-11-19T09:12:20+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-lormetazepam-product/</loc>
				<lastmod>2025-11-19T09:11:04+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-announces-ceo-transition/</loc>
				<lastmod>2025-11-19T09:03:16+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/ardian-acquires-majority-stake-in-neopharmed-gentili/</loc>
				<lastmod>2025-11-19T09:01:34+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-the-european-orladeyo-business-from-biocryst-pharmaceuticals/</loc>
				<lastmod>2025-11-19T08:59:25+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-the-italian-valeas/</loc>
				<lastmod>2025-11-19T08:57:09+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/concerts-of-hope-a-celebration-of-music-inclusion-and-togetherness/</loc>
				<lastmod>2025-11-19T08:49:43+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-s-p-a-places-e750-million-bonds/</loc>
				<lastmod>2025-11-19T08:49:00+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/young-athletes-shine-at-palaluiss-sports-afternoon/</loc>
				<lastmod>2025-11-19T08:44:40+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/en/news-and-communications/neopharmed-gentili-acquires-mdm/</loc>
				<lastmod>2025-11-19T08:42:01+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-prodotti-a-base-di-metoclopramide/</loc>
				<lastmod>2025-11-13T15:13:52+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-colloca-un-ammontare-di-e100-milioni-di-senior-secured-notes/</loc>
				<lastmod>2025-11-13T09:33:13+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/un-impegno-responsabile-e-concreto-verso-le-persone-lambiente-e-la-comunita/</loc>
				<lastmod>2025-11-12T16:52:37+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-sostiene-lo-sport-come-strumento-di-inclusione-e-liberta/</loc>
				<lastmod>2025-11-04T10:24:40+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-completa-lacquisizione-del-business-europeo-di-orladeyo-da-biocryst-pharmaceuticals/</loc>
				<lastmod>2025-10-20T12:05:36+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/ardian-rileva-la-maggioranza-di-neopharmed-gentili-societa-controllata-da-mediolanum-farmaceutici/</loc>
				<lastmod>2025-07-10T14:07:36+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-mdm/</loc>
				<lastmod>2025-07-10T14:07:25+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/appuntamento-con-il-business-tech-forum/</loc>
				<lastmod>2025-07-10T14:07:18+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/pressione-arteriosa-attenzione-a-non-trascurare-i-valori-borderline/</loc>
				<lastmod>2025-07-10T14:06:55+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/covid-19-lo-stress-da-pandemia-peggiora-il-dolore-cronico/</loc>
				<lastmod>2025-07-10T14:06:49+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-prodotti-a-base-di-lormetazepam/</loc>
				<lastmod>2025-07-10T14:06:40+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-dona-farmaci-per-lucraina/</loc>
				<lastmod>2025-07-10T14:06:34+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/al-via-storie-in-ascolto/</loc>
				<lastmod>2025-07-10T14:06:28+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-litaliana-valeas/</loc>
				<lastmod>2025-07-10T14:06:21+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/nb-renaissance-nuovo-socio-per-neopharmed-gentili-e-ardian/</loc>
				<lastmod>2025-07-10T14:06:15+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-dona-50000-euro-per-il-terremoto-in-turchia/</loc>
				<lastmod>2025-07-10T14:06:09+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/disfunzione-erettile-maggiore-consapevolezza-del-problema/</loc>
				<lastmod>2025-07-10T14:06:00+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/sport-e-disabilita-un-connubio-vincente/</loc>
				<lastmod>2025-07-10T14:05:54+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/eric-falcand-e-il-nuovo-ceo-di-neopharmed-gentili/</loc>
				<lastmod>2025-07-10T14:05:47+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/ragazzi-protagonisti-del-pomeriggio-sportivo-al-palaluiss/</loc>
				<lastmod>2025-07-10T14:05:29+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/fab13-le-aziende-storiche-del-made-in-italy-farmaceutico-si-confermano-motore-delleconomia-nazionale/</loc>
				<lastmod>2025-07-10T14:05:08+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-al-fianco-dei-bambini-con-disabilita-per-vivere-un-pomeriggio-di-musica-inclusione-e-condivisione/</loc>
				<lastmod>2025-07-10T14:04:38+00:00</lastmod>
				
			</url>	<url>
				<loc>https://neogen.it/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-annuncia-il-cambio-del-ceo/</loc>
				<lastmod>2025-07-10T13:01:17+00:00</lastmod>
				
			</url></urlset>